 Duncan Wilcox
Concepts (510)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 24 | 2022 | 150 | 5.610 |
Why?
| | Cloaca | 17 | 2021 | 48 | 4.100 |
Why?
| | Urologic Surgical Procedures | 15 | 2022 | 89 | 3.430 |
Why?
| | Reconstructive Surgical Procedures | 7 | 2020 | 253 | 2.550 |
Why?
| | Hypospadias | 6 | 2018 | 25 | 2.530 |
Why?
| | Urethra | 11 | 2020 | 49 | 2.230 |
Why?
| | Lower Urinary Tract Symptoms | 5 | 2021 | 44 | 2.130 |
Why?
| | Hydronephrosis | 7 | 2015 | 33 | 1.950 |
Why?
| | Urinary Bladder, Neurogenic | 4 | 2017 | 25 | 1.840 |
Why?
| | Urinary Bladder Neck Obstruction | 4 | 2017 | 17 | 1.830 |
Why?
| | Urodynamics | 5 | 2019 | 31 | 1.720 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 58 | 1.590 |
Why?
| | Spinal Dysraphism | 6 | 2017 | 31 | 1.580 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 20 | 1.560 |
Why?
| | Urogenital Abnormalities | 7 | 2015 | 38 | 1.320 |
Why?
| | Kidney | 12 | 2019 | 1197 | 1.310 |
Why?
| | Circumcision, Male | 2 | 2019 | 13 | 1.300 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 49 | 1.260 |
Why?
| | Urinary Tract | 5 | 2016 | 31 | 1.260 |
Why?
| | Benzoquinones | 2 | 2017 | 46 | 1.250 |
Why?
| | Urology | 5 | 2020 | 46 | 1.230 |
Why?
| | Infant | 49 | 2022 | 8097 | 1.230 |
Why?
| | Hernias, Diaphragmatic, Congenital | 14 | 1997 | 160 | 1.160 |
Why?
| | Pain, Postoperative | 4 | 2020 | 189 | 1.160 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 71 | 1.110 |
Why?
| | Urinary Incontinence | 6 | 2015 | 56 | 1.100 |
Why?
| | Anorectal Malformations | 4 | 2019 | 64 | 1.080 |
Why?
| | Reoperation | 11 | 2018 | 546 | 1.040 |
Why?
| | Postoperative Complications | 17 | 2020 | 2181 | 1.030 |
Why?
| | Urologic Surgical Procedures, Male | 2 | 2018 | 24 | 1.020 |
Why?
| | Urination | 4 | 2022 | 39 | 1.000 |
Why?
| | Urologic Diseases | 5 | 2018 | 38 | 0.990 |
Why?
| | Ureter | 6 | 2019 | 29 | 0.980 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 242 | 0.980 |
Why?
| | Child, Preschool | 42 | 2020 | 9651 | 0.960 |
Why?
| | Muscle, Smooth | 4 | 2017 | 140 | 0.950 |
Why?
| | Child | 56 | 2021 | 17860 | 0.940 |
Why?
| | Postoperative Care | 3 | 2019 | 237 | 0.940 |
Why?
| | Penis | 3 | 2019 | 29 | 0.920 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 34 | 0.890 |
Why?
| | Kidney Pelvis | 4 | 2022 | 22 | 0.870 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 19 | 0.850 |
Why?
| | Cystostomy | 3 | 2017 | 9 | 0.850 |
Why?
| | Male | 81 | 2022 | 60818 | 0.840 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 39 | 0.830 |
Why?
| | Constipation | 1 | 2021 | 69 | 0.800 |
Why?
| | Calcium Channels | 1 | 2021 | 156 | 0.790 |
Why?
| | Anal Canal | 5 | 2009 | 82 | 0.780 |
Why?
| | Retrospective Studies | 42 | 2022 | 11642 | 0.780 |
Why?
| | Humans | 124 | 2022 | 114578 | 0.770 |
Why?
| | Ultrasonography, Prenatal | 8 | 2014 | 247 | 0.770 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 4 | 0.730 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 22 | 0.730 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 25 | 0.730 |
Why?
| | Follow-Up Studies | 23 | 2018 | 4950 | 0.720 |
Why?
| | Intestine, Large | 1 | 2018 | 14 | 0.720 |
Why?
| | Photography | 1 | 2019 | 100 | 0.720 |
Why?
| | Laparoscopy | 6 | 2022 | 395 | 0.720 |
Why?
| | Rectum | 6 | 2009 | 150 | 0.710 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 18 | 0.710 |
Why?
| | Genitalia, Female | 2 | 2018 | 41 | 0.710 |
Why?
| | Fecal Incontinence | 6 | 2018 | 66 | 0.700 |
Why?
| | Muscle Contraction | 3 | 2019 | 430 | 0.690 |
Why?
| | Female | 76 | 2022 | 63070 | 0.680 |
Why?
| | Perioperative Care | 2 | 2018 | 128 | 0.670 |
Why?
| | Urination Disorders | 2 | 2015 | 15 | 0.670 |
Why?
| | Urinary Bladder Diseases | 3 | 2019 | 16 | 0.660 |
Why?
| | Anesthetics, Local | 2 | 2015 | 87 | 0.660 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 99 | 0.660 |
Why?
| | Preoperative Care | 3 | 2011 | 339 | 0.650 |
Why?
| | Urogenital System | 1 | 2016 | 13 | 0.630 |
Why?
| | Bladder Exstrophy | 6 | 2007 | 17 | 0.620 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.610 |
Why?
| | Infant, Newborn | 28 | 2020 | 5045 | 0.610 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.590 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 29 | 0.560 |
Why?
| | Treatment Outcome | 22 | 2022 | 9190 | 0.550 |
Why?
| | Nephrectomy | 5 | 2009 | 150 | 0.540 |
Why?
| | Infusion Pumps | 1 | 2013 | 33 | 0.530 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 200 | 0.530 |
Why?
| | Recovery of Function | 1 | 2018 | 615 | 0.520 |
Why?
| | Creatinine | 1 | 2015 | 465 | 0.500 |
Why?
| | Enema | 2 | 2006 | 32 | 0.490 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.490 |
Why?
| | Cadherins | 1 | 2014 | 187 | 0.480 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 171 | 0.480 |
Why?
| | Bandages | 1 | 2012 | 27 | 0.470 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 227 | 0.470 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.470 |
Why?
| | Cryptorchidism | 3 | 2019 | 11 | 0.470 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 717 | 0.460 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.450 |
Why?
| | Pediatrics | 3 | 2017 | 1053 | 0.450 |
Why?
| | Vagina | 2 | 2021 | 159 | 0.450 |
Why?
| | Edema | 1 | 2012 | 124 | 0.450 |
Why?
| | Surgical Sponges | 1 | 2011 | 3 | 0.450 |
Why?
| | Stents | 1 | 2014 | 402 | 0.430 |
Why?
| | Dissection | 1 | 2011 | 51 | 0.420 |
Why?
| | Age Factors | 9 | 2019 | 3280 | 0.420 |
Why?
| | Hirschsprung Disease | 5 | 1998 | 53 | 0.420 |
Why?
| | Guideline Adherence | 1 | 2015 | 541 | 0.420 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5137 | 0.410 |
Why?
| | Prospective Studies | 10 | 2021 | 6288 | 0.410 |
Why?
| | Adolescent | 35 | 2021 | 18658 | 0.400 |
Why?
| | Prenatal Diagnosis | 6 | 2007 | 163 | 0.390 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 145 | 0.390 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 497 | 0.390 |
Why?
| | Wilms Tumor | 3 | 2017 | 64 | 0.390 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 62 | 0.380 |
Why?
| | Registries | 1 | 2018 | 1915 | 0.380 |
Why?
| | Cystitis | 1 | 2009 | 23 | 0.380 |
Why?
| | Fetal Diseases | 3 | 2007 | 177 | 0.380 |
Why?
| | Urethral Diseases | 3 | 2020 | 15 | 0.370 |
Why?
| | Disease Models, Animal | 9 | 2018 | 3828 | 0.370 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 225 | 0.370 |
Why?
| | Doxorubicin | 2 | 2021 | 313 | 0.370 |
Why?
| | Animals | 25 | 2022 | 34690 | 0.360 |
Why?
| | Ileum | 2 | 2006 | 91 | 0.360 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 24 | 0.360 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 65 | 0.360 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.350 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 9 | 0.350 |
Why?
| | Signal Transduction | 2 | 2021 | 4891 | 0.340 |
Why?
| | Pulmonary Gas Exchange | 3 | 1997 | 132 | 0.330 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2007 | 518 | 0.330 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 13 | 0.330 |
Why?
| | Urography | 1 | 2006 | 10 | 0.320 |
Why?
| | Cathartics | 1 | 2006 | 12 | 0.320 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 68 | 0.310 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 3 | 0.300 |
Why?
| | Colon | 3 | 2001 | 219 | 0.300 |
Why?
| | Kidney Function Tests | 4 | 2015 | 159 | 0.290 |
Why?
| | Hemorrhage | 1 | 2009 | 603 | 0.280 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 330 | 0.280 |
Why?
| | Animals, Newborn | 6 | 2018 | 843 | 0.270 |
Why?
| | Vincristine | 2 | 2022 | 103 | 0.270 |
Why?
| | Pain Measurement | 3 | 2015 | 528 | 0.270 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 51 | 0.270 |
Why?
| | Postnatal Care | 2 | 2015 | 71 | 0.270 |
Why?
| | Mass Screening | 1 | 2012 | 1066 | 0.270 |
Why?
| | Urinary Diversion | 4 | 2015 | 11 | 0.260 |
Why?
| | Fetus | 1 | 2007 | 653 | 0.260 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 145 | 0.250 |
Why?
| | Prognosis | 5 | 2018 | 3546 | 0.250 |
Why?
| | Sacrum | 1 | 2003 | 52 | 0.240 |
Why?
| | Surgical Flaps | 1 | 2003 | 125 | 0.240 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 546 | 0.230 |
Why?
| | Muscle Development | 1 | 2003 | 108 | 0.230 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.230 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 120 | 0.230 |
Why?
| | Analgesia | 2 | 2020 | 98 | 0.230 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 91 | 0.220 |
Why?
| | Incidence | 4 | 2019 | 2454 | 0.220 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 84 | 0.220 |
Why?
| | Sheep | 10 | 1997 | 758 | 0.220 |
Why?
| | Ultrasonography | 4 | 2015 | 783 | 0.220 |
Why?
| | Catheterization | 3 | 2013 | 175 | 0.220 |
Why?
| | Hydrocephalus | 2 | 2011 | 68 | 0.210 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 11 | 0.210 |
Why?
| | Gastrostomy | 2 | 1999 | 87 | 0.210 |
Why?
| | Lung | 5 | 1997 | 3558 | 0.210 |
Why?
| | Robotics | 1 | 2022 | 77 | 0.210 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 39 | 0.210 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 104 | 0.200 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 9 | 0.200 |
Why?
| | Orchiopexy | 1 | 2019 | 5 | 0.200 |
Why?
| | Perinatology | 1 | 1999 | 3 | 0.200 |
Why?
| | Length of Stay | 4 | 2020 | 1071 | 0.200 |
Why?
| | Hypertrophy | 2 | 2019 | 124 | 0.200 |
Why?
| | Cell Hypoxia | 2 | 2014 | 237 | 0.200 |
Why?
| | Mice | 9 | 2022 | 15432 | 0.200 |
Why?
| | Nephrology | 1 | 1999 | 31 | 0.190 |
Why?
| | Cell Division | 1 | 2002 | 857 | 0.190 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 10 | 0.190 |
Why?
| | Nephrology Nursing | 1 | 2019 | 5 | 0.190 |
Why?
| | Reflex | 2 | 2018 | 72 | 0.190 |
Why?
| | Atlases as Topic | 1 | 2019 | 4 | 0.190 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 8 | 0.190 |
Why?
| | Risk Assessment | 5 | 2017 | 3208 | 0.190 |
Why?
| | Muscle Relaxation | 1 | 2019 | 33 | 0.190 |
Why?
| | Myosin Light Chains | 1 | 2019 | 34 | 0.190 |
Why?
| | Extracellular Matrix | 1 | 2003 | 413 | 0.190 |
Why?
| | Diet | 1 | 2006 | 1071 | 0.190 |
Why?
| | Pediatric Nursing | 1 | 2019 | 42 | 0.180 |
Why?
| | Anxiety, Separation | 1 | 2018 | 21 | 0.180 |
Why?
| | Umbilicus | 1 | 1998 | 16 | 0.180 |
Why?
| | Maternal Deprivation | 1 | 2018 | 30 | 0.180 |
Why?
| | Twins, Conjoined | 1 | 1998 | 7 | 0.180 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 117 | 0.180 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 588 | 0.180 |
Why?
| | Phospholipids | 2 | 1997 | 203 | 0.180 |
Why?
| | Cancer Survivors | 1 | 2021 | 157 | 0.180 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 129 | 0.180 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 7 | 0.180 |
Why?
| | Diagnostic Errors | 1 | 2019 | 158 | 0.170 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 135 | 0.170 |
Why?
| | Transition to Adult Care | 1 | 2018 | 53 | 0.170 |
Why?
| | Medical Errors | 1 | 2019 | 102 | 0.170 |
Why?
| | Kidney Diseases | 4 | 2009 | 402 | 0.170 |
Why?
| | Reference Values | 2 | 2018 | 852 | 0.170 |
Why?
| | Urinary Catheterization | 2 | 2001 | 28 | 0.170 |
Why?
| | Sex Factors | 4 | 2017 | 1971 | 0.170 |
Why?
| | Genitalia | 3 | 2019 | 27 | 0.170 |
Why?
| | Genitalia, Male | 1 | 1997 | 12 | 0.170 |
Why?
| | Informed Consent | 1 | 1998 | 165 | 0.170 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 24 | 0.170 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 2 | 0.170 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 7 | 0.170 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 6 | 0.170 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 10 | 0.170 |
Why?
| | Cholelithiasis | 1 | 1997 | 33 | 0.160 |
Why?
| | Gallstones | 1 | 1997 | 26 | 0.160 |
Why?
| | Case-Control Studies | 3 | 2020 | 3249 | 0.160 |
Why?
| | Algorithms | 3 | 2018 | 1502 | 0.160 |
Why?
| | Postoperative Period | 1 | 2018 | 310 | 0.160 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 262 | 0.160 |
Why?
| | Time Factors | 6 | 2019 | 7029 | 0.160 |
Why?
| | Outpatients | 1 | 2019 | 263 | 0.160 |
Why?
| | Fluorocarbons | 1 | 1997 | 67 | 0.160 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 191 | 0.150 |
Why?
| | Vulva | 1 | 2016 | 22 | 0.150 |
Why?
| | Endoscopy | 1 | 1998 | 239 | 0.150 |
Why?
| | Patient Safety | 1 | 2019 | 307 | 0.150 |
Why?
| | Pneumothorax | 1 | 1995 | 36 | 0.150 |
Why?
| | Medical Oncology | 1 | 2017 | 207 | 0.150 |
Why?
| | Risk Factors | 3 | 2018 | 9078 | 0.150 |
Why?
| | Sphingomyelins | 1 | 1995 | 25 | 0.140 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 22 | 0.140 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 46 | 0.140 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 23 | 0.140 |
Why?
| | Toothbrushing | 1 | 1994 | 7 | 0.140 |
Why?
| | Lung Compliance | 2 | 1995 | 53 | 0.140 |
Why?
| | Amniotic Fluid | 1 | 1995 | 70 | 0.140 |
Why?
| | Bulimia | 1 | 1994 | 30 | 0.140 |
Why?
| | Bone and Bones | 1 | 1997 | 259 | 0.140 |
Why?
| | Desmin | 2 | 2006 | 33 | 0.140 |
Why?
| | Attitude to Health | 1 | 1998 | 420 | 0.140 |
Why?
| | Appendix | 3 | 2001 | 28 | 0.140 |
Why?
| | Scrotum | 2 | 2007 | 24 | 0.140 |
Why?
| | Triiodothyronine | 1 | 1994 | 51 | 0.130 |
Why?
| | Laparotomy | 1 | 1994 | 113 | 0.130 |
Why?
| | Pilot Projects | 1 | 2019 | 1420 | 0.130 |
Why?
| | Meconium | 1 | 1993 | 8 | 0.130 |
Why?
| | Organ Size | 2 | 2014 | 503 | 0.130 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 406 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1600 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 456 | 0.130 |
Why?
| | ROC Curve | 2 | 2015 | 489 | 0.130 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1920 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2002 | 1807 | 0.130 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 131 | 0.130 |
Why?
| | Pregnancy | 10 | 2007 | 5267 | 0.130 |
Why?
| | Phenyl Ethers | 1 | 1993 | 3 | 0.130 |
Why?
| | Foreign Bodies | 1 | 1994 | 92 | 0.130 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 33 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 1997 | 555 | 0.120 |
Why?
| | Perineum | 2 | 2019 | 29 | 0.120 |
Why?
| | Foreskin | 1 | 2012 | 8 | 0.120 |
Why?
| | Fetal Blood | 1 | 1994 | 255 | 0.120 |
Why?
| | Logistic Models | 1 | 2018 | 2051 | 0.120 |
Why?
| | Syndrome | 2 | 2007 | 342 | 0.120 |
Why?
| | Epispadias | 2 | 2002 | 4 | 0.120 |
Why?
| | Nitric Oxide | 2 | 1997 | 897 | 0.120 |
Why?
| | Infant Food | 1 | 1993 | 67 | 0.120 |
Why?
| | Young Adult | 7 | 2020 | 10987 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 171 | 0.120 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 4 | 0.110 |
Why?
| | Gestational Age | 4 | 2004 | 762 | 0.110 |
Why?
| | Comorbidity | 2 | 2016 | 1645 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 37 | 0.110 |
Why?
| | Hydrocortisone | 1 | 1994 | 331 | 0.110 |
Why?
| | Apoptosis | 1 | 2002 | 2607 | 0.110 |
Why?
| | Shock | 1 | 1993 | 92 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2847 | 0.100 |
Why?
| | Pain Management | 1 | 2013 | 303 | 0.100 |
Why?
| | Parents | 1 | 1998 | 1149 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1994 | 0.100 |
Why?
| | Hernia, Ventral | 1 | 2010 | 22 | 0.100 |
Why?
| | Databases, Factual | 3 | 2019 | 1161 | 0.100 |
Why?
| | Ischemia | 1 | 1993 | 316 | 0.100 |
Why?
| | Intestines | 3 | 2020 | 309 | 0.100 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 7 | 0.100 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.100 |
Why?
| | Dysgerminoma | 1 | 2009 | 3 | 0.100 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 191 | 0.100 |
Why?
| | Urolithiasis | 1 | 2009 | 7 | 0.100 |
Why?
| | Acute Disease | 1 | 2012 | 993 | 0.090 |
Why?
| | BK Virus | 1 | 2009 | 18 | 0.090 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 20 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 49 | 0.090 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 66 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1783 | 0.090 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 52 | 0.090 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 624 | 0.090 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.090 |
Why?
| | Cohort Studies | 2 | 2016 | 5000 | 0.090 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 268 | 0.090 |
Why?
| | Neoplasms | 1 | 2021 | 2066 | 0.090 |
Why?
| | Disease Progression | 1 | 2015 | 2486 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 728 | 0.080 |
Why?
| | Testis | 1 | 2007 | 123 | 0.080 |
Why?
| | Myogenin | 1 | 2006 | 18 | 0.080 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 6 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 171 | 0.080 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 20 | 0.080 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1081 | 0.080 |
Why?
| | Hematocolpos | 1 | 2005 | 2 | 0.080 |
Why?
| | Calcinosis | 1 | 2009 | 292 | 0.080 |
Why?
| | Urinary Bladder Fistula | 1 | 2005 | 4 | 0.080 |
Why?
| | Adult | 10 | 2021 | 32077 | 0.080 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 216 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2009 | 1496 | 0.070 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 26 | 0.070 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 22 | 0.070 |
Why?
| | Defecation | 1 | 2004 | 16 | 0.070 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 350 | 0.070 |
Why?
| | Nutritional Support | 1 | 2004 | 29 | 0.070 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 14 | 0.070 |
Why?
| | Coitus | 1 | 2003 | 31 | 0.060 |
Why?
| | Salvage Therapy | 1 | 2004 | 139 | 0.060 |
Why?
| | Rabbits | 2 | 1996 | 794 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3485 | 0.060 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 30 | 0.060 |
Why?
| | Fertility | 1 | 2004 | 132 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2007 | 383 | 0.060 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.060 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 13 | 0.060 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.060 |
Why?
| | Colostomy | 3 | 2004 | 22 | 0.060 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 6 | 0.060 |
Why?
| | Ascites | 1 | 2003 | 36 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1541 | 0.060 |
Why?
| | Urine | 1 | 2003 | 62 | 0.060 |
Why?
| | Azo Compounds | 1 | 2003 | 28 | 0.060 |
Why?
| | Urothelium | 1 | 2003 | 31 | 0.060 |
Why?
| | Urinary Sphincter, Artificial | 1 | 2002 | 3 | 0.060 |
Why?
| | Mandelic Acids | 1 | 2002 | 2 | 0.060 |
Why?
| | Oligohydramnios | 1 | 2002 | 8 | 0.060 |
Why?
| | Endocrinology | 1 | 2003 | 89 | 0.060 |
Why?
| | Cholinergic Antagonists | 1 | 2002 | 27 | 0.060 |
Why?
| | Puberty | 1 | 2003 | 139 | 0.060 |
Why?
| | Pelvic Neoplasms | 1 | 2002 | 22 | 0.060 |
Why?
| | Mucous Membrane | 1 | 2003 | 116 | 0.060 |
Why?
| | Pain Threshold | 1 | 2002 | 108 | 0.060 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 56 | 0.060 |
Why?
| | Observer Variation | 1 | 2003 | 336 | 0.060 |
Why?
| | Fatal Outcome | 2 | 2007 | 315 | 0.060 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 56 | 0.060 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2926 | 0.060 |
Why?
| | Transplantation, Autologous | 1 | 2002 | 196 | 0.060 |
Why?
| | Blood Pressure | 4 | 1997 | 1726 | 0.060 |
Why?
| | Proteolipids | 2 | 2000 | 25 | 0.060 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.060 |
Why?
| | Learning Curve | 1 | 2022 | 65 | 0.050 |
Why?
| | Cysts | 1 | 2002 | 85 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2007 | 808 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 402 | 0.050 |
Why?
| | Urinary Fistula | 1 | 2000 | 6 | 0.050 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 36 | 0.050 |
Why?
| | Radiography | 1 | 2003 | 850 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2379 | 0.050 |
Why?
| | Gastric Fistula | 1 | 1999 | 4 | 0.050 |
Why?
| | Jejunal Diseases | 1 | 1999 | 7 | 0.050 |
Why?
| | Actins | 1 | 2002 | 367 | 0.050 |
Why?
| | Intestinal Fistula | 1 | 1999 | 13 | 0.050 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 9 | 0.050 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 9 | 0.050 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 26 | 0.050 |
Why?
| | Blotting, Western | 1 | 2003 | 1296 | 0.050 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 59 | 0.050 |
Why?
| | Pelvis | 1 | 1999 | 79 | 0.050 |
Why?
| | Digestive System Diseases | 1 | 1998 | 23 | 0.050 |
Why?
| | Rectal Prolapse | 1 | 2018 | 19 | 0.050 |
Why?
| | Biological Variation, Population | 1 | 2018 | 17 | 0.050 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 27 | 0.050 |
Why?
| | Quality of Life | 1 | 2009 | 2230 | 0.050 |
Why?
| | Counseling | 1 | 2002 | 362 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 5 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 146 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 35 | 0.040 |
Why?
| | Mutation | 1 | 2009 | 3378 | 0.040 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 10 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2003 | 686 | 0.040 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 85 | 0.040 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 31 | 0.040 |
Why?
| | Ampulla of Vater | 1 | 1997 | 22 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 53 | 0.040 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 107 | 0.040 |
Why?
| | Ileal Diseases | 1 | 1996 | 13 | 0.040 |
Why?
| | Duodenum | 1 | 1997 | 55 | 0.040 |
Why?
| | Survival Analysis | 2 | 2017 | 1410 | 0.040 |
Why?
| | Barrett Esophagus | 1 | 1999 | 144 | 0.040 |
Why?
| | Stomach | 1 | 1997 | 94 | 0.040 |
Why?
| | Teratoma | 1 | 2017 | 91 | 0.040 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 129 | 0.040 |
Why?
| | Collagen | 2 | 1995 | 432 | 0.040 |
Why?
| | Operative Time | 1 | 2016 | 112 | 0.040 |
Why?
| | Wound Healing | 1 | 1998 | 272 | 0.040 |
Why?
| | Umbilical Cord | 1 | 1996 | 86 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1315 | 0.040 |
Why?
| | Clinical Protocols | 1 | 1997 | 246 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2017 | 685 | 0.040 |
Why?
| | Rats | 2 | 1996 | 6201 | 0.040 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 8 | 0.040 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 23 | 0.040 |
Why?
| | Tunica Intima | 1 | 1995 | 81 | 0.030 |
Why?
| | United States | 1 | 2011 | 12551 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1728 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 44 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 610 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 34 | 0.030 |
Why?
| | Swine | 1 | 1996 | 725 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 64 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 952 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 558 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 86 | 0.030 |
Why?
| | Middle Aged | 5 | 2021 | 28854 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 3 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 369 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 5 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 11 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 8 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 15 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 605 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 474 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 988 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2011 | 12 | 0.030 |
Why?
| | Frameshift Mutation | 1 | 2011 | 27 | 0.030 |
Why?
| | Necrosis | 1 | 1993 | 227 | 0.030 |
Why?
| | Consanguinity | 1 | 2011 | 47 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 166 | 0.030 |
Why?
| | Colorado | 2 | 2018 | 4488 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 208 | 0.030 |
Why?
| | Colitis | 1 | 1993 | 214 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2013 | 610 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 707 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 18 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 27 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 139 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1649 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2278 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 51 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 149 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 81 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 10 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 85 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1547 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 24 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1217 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 73 | 0.020 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 5 | 0.020 |
Why?
| | Intestinal Atresia | 1 | 2004 | 10 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 23 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2835 | 0.020 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 38 | 0.020 |
Why?
| | Enteritis | 1 | 2004 | 65 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1419 | 0.020 |
Why?
| | Gender Identity | 1 | 2003 | 82 | 0.020 |
Why?
| | Europe | 1 | 2003 | 332 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1164 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 405 | 0.010 |
Why?
| | Abdomen | 1 | 2002 | 124 | 0.010 |
Why?
| | Hip Joint | 1 | 2002 | 125 | 0.010 |
Why?
| | Consensus | 1 | 2003 | 458 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 2003 | 341 | 0.010 |
Why?
| | Movement | 1 | 2002 | 275 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 101 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 1020 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 764 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 37 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 454 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 957 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 36 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 336 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1352 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 152 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2000 | 396 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 1859 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4281 | 0.010 |
Why?
| | Skin | 1 | 2002 | 683 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 4741 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 189 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 133 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 49 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 502 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 48 | 0.010 |
Why?
| | Venules | 1 | 1995 | 14 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 284 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 32 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 48 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 559 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 42 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1049 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 52 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 125 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 23 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 254 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 238 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 578 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 667 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 226 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 871 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2002 | 4408 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 622 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 913 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 728 | 0.010 |
Why?
| | Aged | 2 | 1997 | 20219 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1993 | 6819 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|